Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Risk And Benefit, Quantified: CDRH Expands Use Of New Statistical Framework

02 Jan 2012

Related Content

Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program

10 Oct 2011

Risk-Benefit Guidance Aims To Improve Pre-Market Review Predictability

22 Aug 2011

CDRH's Innovation Pathway: A Quicker Route For Breakthrough Devices?

14 Feb 2011

FDA, Researchers Flag Safety Problems With Vena Cava Filters

16 Aug 2010

Additional Topics

Regulation Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.